Immutep Ltd
OTC:PRRUF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
Immutep Ltd
OTC:PRRUF
|
AU |
|
D
|
Danaher Corp
XMUN:DAP
|
US |
|
M
|
Minerva Neurosciences Inc
F:4MN
|
US |
|
F
|
Federal Home Loan Mortgage Corp
XMUN:FHL
|
US |
|
P
|
Papoutsanis Industrial and Commercial of Consumer Goods SA
ATHEX:PAP
|
GR |
|
B
|
Bayer AG
F:BAYA
|
DE |
|
Alpha HPA Ltd
F:3AU
|
AU |
|
I
|
International Lithium Corp
F:IAH
|
CA |
|
L
|
Lloyds Banking Group PLC
DUS:LLD
|
UK |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is PRRUF's stock price target?
Not Available
PRRUF does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Immutep Ltd?
Projected CAGR
307%
Over the last 13 years, the compound annual growth rate for Revenue has been -28%. The projected CAGR for the next 7 years is 307%.